GFT505
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for GFT505, covering 2011-01-07 to 2022-11-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]